HK Stock MarketDetailed Quotes

03320 CHINARES PHARMA

Watchlist
  • 5.700
  • +0.080+1.42%
Noon Break Nov 5 11:58 CST
35.81BMarket Cap8.65P/E (TTM)

CHINARES PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CHINARES PHARMA Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: HKD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/H1-- / 168.463B--
--2024/H2-- / 147.261B--
Aug 29, 20242024/H1141.282B / ----
Mar 26, 20242023/H2114.635B / 136.356B--
Aug 31, 20232023/H1138.940B / 137.924B--
DatePeriodRevenue/EstimateEarnings Call
--2025/H1-- / 168.463B--
--2024/H2-- / 147.261B--
Aug 29, 20242024/H1141.282B / ----
Mar 26, 20242023/H2114.635B / 136.356B--
Aug 31, 20232023/H1138.940B / 137.924B--

Unlock Free Earnings Estimates

CHINARES PHARMA Earnings Reports

  • CHINARES PHARMA: ANNOUNCEMENTUNAUDITED FINANCIAL RESULTS OFDONG-E-E-JIAO FOR THE NINE MONTHS ENDED30 SEPTEMBER 2024

    Oct 30 08:23 ET

  • CHINARES PHARMA: ANNOUNCEMENTUNAUDITED FINANCIAL RESULTS OFCR SANJIU FOR THE NINE MONTHS ENDED30 SEPTEMBER 2024

    Oct 25 08:50 ET

  • CHINARES PHARMA: ANNOUNCEMENTUNAUDITED FINANCIAL RESULTS OFJIANGZHONG PHARMACEUTICALFOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024

    Oct 25 07:49 ET

  • CHINARES PHARMA: ANNOUNCEMENTUNAUDITED FINANCIAL RESULTS OFKPC FOR THE NINE MONTHS ENDED30 SEPTEMBER 2024

    Oct 25 07:04 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 4, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Latest Price
    % Chg

    No Data